Core Scientific (CORZ) said Monday it intends to offer $500 million total principal amount of convertible senior notes due 2031 in a private offering.
The notes will mature on June 15, 2031, and will be redeemable in whole or in part on or after June 22, 2028, the company said, adding that it plans to grant the initial purchasers a 13-day time period to buy up to an additional $75 million principal amount of the notes.
Core Scientific said it plans to use the net proceeds for general corporate purposes, including working capital, operating expenditures, capital expenses, acquisitions of complementary businesses, or repurchases of its securities.
Shares of the company were down 5% in recent Monday premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.